https://pharmatimes.com in-depth news, features and insights for the pharmaceutical and healthcare sectors Thu, 10 Apr 2025 11:31:18 +0000 en-US hourly 1 https://pharmatimes.com/wp-content/uploads/2023/11/PT-icon-150x150.png https://pharmatimes.com 32 32 232894315 https://pharmatimes.com/news/first-treatment-for-common-bladder-cancer-recommended-by-nice/ Thu, 10 Apr 2025 11:22:53 +0000 https://pharmatimes.com/?p=103110 Johnson & Johnson’s Balversa was found to extend the lives of urothelial cancer patients with a genetic alteration

]]> 103110 https://pharmatimes.com/news/lab-grown-lung-cancer-cells-shows-potential-to-revolutionise-treatment/ Thu, 10 Apr 2025 11:21:07 +0000 https://pharmatimes.com/?p=103113 The model could lead to more targeted treatments for the disease

]]> 103113 https://pharmatimes.com/news/nhs-launches-spring-covid-19-booster-campaign/ Wed, 09 Apr 2025 11:20:57 +0000 https://pharmatimes.com/?p=103108 An estimated 7.5 million people will be invited to receive the booster

]]> 103108 https://pharmatimes.com/news/skycell-and-microsoft-partner-to-improve-pharma-supply-chains/ Wed, 09 Apr 2025 11:18:57 +0000 https://pharmatimes.com/?p=103105 AI-powered SkyMind is designed to improve efficiency, compliance and decision-making

]]> 103105